Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer

Two out of three diseases of the prostate gland affect aging men worldwide. Benign prostatic hyperplasia (BPH) is a noncancerous enlargement affecting millions of men. Prostate cancer (PCa) in turn is the second leading cause of cancer death. The factors influencing the occurrence of BPH and PCa are...

Full description

Bibliographic Details
Main Authors: Weronika Ratajczak, Michał Lubkowski, Anna Lubkowska
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/2/897
_version_ 1797493304685756416
author Weronika Ratajczak
Michał Lubkowski
Anna Lubkowska
author_facet Weronika Ratajczak
Michał Lubkowski
Anna Lubkowska
author_sort Weronika Ratajczak
collection DOAJ
description Two out of three diseases of the prostate gland affect aging men worldwide. Benign prostatic hyperplasia (BPH) is a noncancerous enlargement affecting millions of men. Prostate cancer (PCa) in turn is the second leading cause of cancer death. The factors influencing the occurrence of BPH and PCa are different; however, in the course of these two diseases, the overexpression of heat shock proteins is observed. Heat shock proteins (HSPs), chaperone proteins, are known to be one of the main proteins playing a role in maintaining cell homeostasis. HSPs take part in the process of the proper folding of newly formed proteins, and participate in the renaturation of damaged proteins. In addition, they are involved in the transport of specific proteins to the appropriate cell organelles and directing damaged proteins to proteasomes or lysosomes. Their function is to protect the proteins against degradation factors that are produced during cellular stress. HSPs are also involved in modulating the immune response and the process of apoptosis. One well-known factor affecting HSPs is the androgen receptor (AR)—a main player involved in the development of BPH and the progression of prostate cancer. HSPs play a cytoprotective role and determine the survival of cancer cells. These chaperones are often upregulated in malignancies and play an indispensable role in tumor progression. Therefore, HSPs are considered as one of the therapeutic targets in anti-cancer therapies. In this review article, we discuss the role of different HSPs in prostate diseases, and their potential as therapeutic targets.
first_indexed 2024-03-10T01:18:06Z
format Article
id doaj.art-713fa93657d949e7b2c1621662615185
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:18:06Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-713fa93657d949e7b2c16216626151852023-11-23T14:06:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-01-0123289710.3390/ijms23020897Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate CancerWeronika Ratajczak0Michał Lubkowski1Anna Lubkowska2Department of Functional Diagnostics and Physical Medicine, Pomeranian Medical University, Żołnierska 54, 71-210 Szczecin, PolandStudent Research at the Chair and Department of Functional Diagnostics and Physical Medicine, Pomeranian Medical University, Żołnierska 54, 71-210 Szczecin, PolandDepartment of Functional Diagnostics and Physical Medicine, Pomeranian Medical University, Żołnierska 54, 71-210 Szczecin, PolandTwo out of three diseases of the prostate gland affect aging men worldwide. Benign prostatic hyperplasia (BPH) is a noncancerous enlargement affecting millions of men. Prostate cancer (PCa) in turn is the second leading cause of cancer death. The factors influencing the occurrence of BPH and PCa are different; however, in the course of these two diseases, the overexpression of heat shock proteins is observed. Heat shock proteins (HSPs), chaperone proteins, are known to be one of the main proteins playing a role in maintaining cell homeostasis. HSPs take part in the process of the proper folding of newly formed proteins, and participate in the renaturation of damaged proteins. In addition, they are involved in the transport of specific proteins to the appropriate cell organelles and directing damaged proteins to proteasomes or lysosomes. Their function is to protect the proteins against degradation factors that are produced during cellular stress. HSPs are also involved in modulating the immune response and the process of apoptosis. One well-known factor affecting HSPs is the androgen receptor (AR)—a main player involved in the development of BPH and the progression of prostate cancer. HSPs play a cytoprotective role and determine the survival of cancer cells. These chaperones are often upregulated in malignancies and play an indispensable role in tumor progression. Therefore, HSPs are considered as one of the therapeutic targets in anti-cancer therapies. In this review article, we discuss the role of different HSPs in prostate diseases, and their potential as therapeutic targets.https://www.mdpi.com/1422-0067/23/2/897heat shock proteinsprostate cancerbenign prostatic hyperplasiaprostate diseases
spellingShingle Weronika Ratajczak
Michał Lubkowski
Anna Lubkowska
Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
International Journal of Molecular Sciences
heat shock proteins
prostate cancer
benign prostatic hyperplasia
prostate diseases
title Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
title_full Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
title_fullStr Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
title_full_unstemmed Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
title_short Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
title_sort heat shock proteins in benign prostatic hyperplasia and prostate cancer
topic heat shock proteins
prostate cancer
benign prostatic hyperplasia
prostate diseases
url https://www.mdpi.com/1422-0067/23/2/897
work_keys_str_mv AT weronikaratajczak heatshockproteinsinbenignprostatichyperplasiaandprostatecancer
AT michałlubkowski heatshockproteinsinbenignprostatichyperplasiaandprostatecancer
AT annalubkowska heatshockproteinsinbenignprostatichyperplasiaandprostatecancer